Search Results - "Hecht, Todd E. H."

Thromboembolic Events in Users of Warfarin Treated with Different Skeletal Muscle Relaxants by Leonard, Charles E, Brensinger, Colleen M, Bilker, Warren B, Soprano, Samantha E, Dhopeshwarkar, Neil, Hecht, Todd E H, Kasner, Scott E, Nutescu, Edith A, Holbrook, Anne, Carr, Matthew, Ashcroft, Darren M, Chen, Cheng, Hennessy, Sean

“…Background and Objectives: Warfarin and a skeletal muscle relaxant are co-treatments in nearly a quarter-million annual United States (US) office visits…”
Get full text

Pharmacoepidemiologic Screening of Potential Oral Anticoagulant Drug Interactions Leading to Thromboembolic Events by Zhou, Meijia, Leonard, Charles E., Brensinger, Colleen M., Bilker, Warren B., Kimmel, Stephen E., Hecht, Todd E. H., Hennessy, Sean

“…Drug‐drug interactions (DDIs) with oral anticoagulants may lead to under‐anticoagulation and increased risk of thromboembolism. Although warfarin is…”
Get full text

Effectiveness of a novel and scalable clinical decision support intervention to improve venous thromboembolism prophylaxis: a quasi-experimental study by Umscheid, Craig A, Hanish, Asaf, Chittams, Jesse, Weiner, Mark G, Hecht, Todd E H

“…Venous thromboembolism (VTE) causes morbidity and mortality in hospitalized patients, and regulators and payors are encouraging the use of systems to prevent…”
Get full text

A randomized trial of lottery-based incentives and reminders to improve warfarin adherence: the Warfarin Incentives (WIN2) Trial by Kimmel, Stephen E., Troxel, Andrea B., French, Benjamin, Loewenstein, George, Doshi, Jalpa A., Hecht, Todd E. H., Laskin, Mitchell, Brensinger, Colleen M., Meussner, Chris, Volpp, Kevin

“…Background Previous research has suggested that daily lottery incentives could improve medication adherence. Such daily incentives include implicit reminders…”
Get full text

Bleeding risk by intensity of anticoagulation in critically ill patients with COVID‐19: A retrospective cohort study by Halaby, Rim, Cuker, Adam, Yui, Jennifer, Matthews, Andrew, Ishaaya, Ella, Traxler, Elizabeth, Domenico, Christopher, Cooper, Tara, Tierney, Ann, Niami, Pardis, Rijst, Nathalie, Adusumalli, Srinath, Gutsche, Jacob, Giri, Jay, Pugliese, Steven, Hecht, Todd E. H., Pishko, Allyson M.

“…Background Studies report hypercoagulability in coronavirus disease 2019 (COVID‐19), leading many institutions to escalate anticoagulation intensity for…”
Get full text

Nonpharmacologic interventions for prevention of catheter-related thrombosis: A systematic review by Mitchell, Matthew D., PhD, Agarwal, Rajender, MD, MPH, Hecht, Todd E.H., MD, Umscheid, Craig A., MD, MSCE

“…Abstract Purpose The aim of this study was to summarize randomized controlled trials (RCTs) of nonpharmacologic interventions for prevention of…”
Get full text

Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative by Barkoudah, Ebrahim, Piazza, Gregory, Hecht, Todd E.H., Grant, Paul, Deitelzweig, Steven, Fang, Margaret C., Fanikos, John, Kao, Cheng-Kai, Barnes, Geoffrey D., Chen, Thomas, Ramishvili, Téa, Schnipper, Jeffrey L., Goldstein, Jennifer N., Ruff, Christian T., Kaatz, Scott, Schwartz, Aviva, Connors, Jean M., Goldhaber, Samuel Z.

“…Hospitalized patients with acute medical illnesses are at risk for venous thromboembolism (VTE) during and after a hospital stay. Risk factors include physical…”
Get full text

Presentation and management of acute fistulization of a foregut duplication cyst by Sarkar, Monika, MD, Wood, Richard, MD, Oh, Young, MD, Hecht, Todd E.H., MD, Kaiser, Larry, MD, Wasserstein, Alan, MD, Kochman, Michael L., MD

Get full text

Off-brand: A 6-year study of medication brand and generic name usage in a multifacility academic healthcare system by Steinkamp, Jackson, Hecht, Todd E H, Hennessy, Sean, Leonard, Charles E, Shu, Di, Airan-Javia, Subha

“…Usage of medication brand names in electronic health records may introduce conflicts of interest, perpetuate false perceptions of brand superiority, alter…”
Get full text

A unit-based intervention aimed at improving patient adherence to pharmacological thromboprophylaxis by Baillie, Charles Alexander, Guevara, James P, Boston, Raymond C, Hecht, Todd E H

“…Pharmacological thromboprophylaxis is necessary among many hospitalised patients to prevent venous thromboembolism (VTE). However, a significant number of…”
Get more information

COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic by Parks, Anna L., Auerbach, Andrew D., Schnipper, Jeffrey L., Anstey, James E., Sterken, David G., Hecht, Todd E.H., Fang, Margaret C., Vaughn, Valerie M., Dunn, Andrew S., Linker, Anne S., Hunt, Daniel P., Choi, Justin J., Brotman, Daniel J., Streiff, Michael B., Mattison, Melissa L.P., Pappas, Matthew A., Greysen, S. Ryan, Hemsey, David F., Dapaah-Afriyie, Kwame, Ahuja, Neera, Collins, William J., Herzig, Shoshana J., Bhandari, Sanjay, Schumacher, Eric R., Duggirala, Vijay S., O'Leary, Kevin J., Menard, Geraldine E., Lin, Michael Y.

“…As the Coronavirus disease 2019 (COVID-19) pandemic spread to the US, so too did descriptions of an associated coagulopathy and thrombotic complications…”
Get full text

Venous thromboembolism prophylaxis by Hecht, Todd E H

Get full text

Venous thromboembolism prophylaxis for patients undergoing bariatric surgery: a systematic review by Agarwal, Rajender, M.D., M.P.H, Hecht, Todd E.H., M.D, Lazo, Myra C., M.S.P.A.-C, Umscheid, Craig A., M.D., M.S.C.E

Get full text

Aggressive venous thromboembolism prophylaxis reduces VTE events in vascular surgery patients by Durinka, Joel B, Hecht, Todd Eh, Layne, Andrew J, Jackson, Benjamin M, Woo, Edward Y, Fairman, Ronald M, Rohrbach, Jeffery I, Wang, Grace J

“…Venous thromboembolism (VTE) is a potentially preventable complication following surgery. There is variation with regard to the most effective mode of…”
Get more information